Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 03.11.2021.

#sponsor
#showcase
#lifesciences
#spotlight
#InVivo
#MemberSpotlight
#RNAi
#SARSCoV2
#COVID19

Startups

@Forbes shared
On Nov 1, 2021
RT @alexrkonrad: A chance encounter with Sequoia's Doug Leone inspired 11.2 Capital founder Shelley Zhuang into a career in VC. Two decades later, the Las Vegas-based investor has raised a $101M second fund to invest in more highly-technical, "deep tech" startups. https://t.co/Bx3UDfkSns
Open
VC Firm 11.2 Capital Raises $101 Million To Back More ‘Deep Tech’ Companies Like Ginkgo Bioworks And Hinge Health

VC Firm 11.2 Capital Raises $101 Million To Back More ‘Deep Tech’ Companies Like Ginkgo Bioworks And Hinge Health

Las Vegas-based Shelley Zhuang was an early investor in Cruise, Ginkgo Bioworks and Hinge Health. Now she has $101,010,101 for a second "deep tech" fund.

@matthewherper shared
On Oct 28, 2021
Wow. Big passing of the torch here. https://t.co/qqmFMqcrSo
Open
Alnylam Announces Planned CEO Leadership Transition

Alnylam Announces Planned CEO Leadership Transition

Alnylam Pharmaceuticals Press Release | Oct 28, 2021

@big4bio shared
On Nov 3, 2021
.@MassBio spotlighted @ExploraBioLabs to #showcase the good work they are doing to advance the #lifesciences industry and support the patients MassBio serves. MassBio spoke with Nathaniel "Sandy" Paige, CEO of Explora. #spotlight #sponsor Learn more here: https://t.co/v1bmuMuTM1
Open
Member Spotlight: Q&A with Explora BioLabs

Member Spotlight: Q&A with Explora BioLabs

In November, we spoke with Nathaniel "Sandy" Paige, CEO, Explora BioLabs.

@Forbes shared
On Oct 28, 2021
RT @mcgrathmag: It's Thursday, and you (might) know what that means: @ForbesWomen newsletter day! Here's what you missed if you haven't signed up to get our weekly dose of female entrepreneurship to your inbox: https://t.co/l4W6U41lqQ
Open
ForbesWomen Weekly: What Rent The Runway’s Founders Are Worth, How To Improve Your Focus, And More

ForbesWomen Weekly: What Rent The Runway’s Founders Are Worth, How To Improve Your Focus, And More

This is this week’s ForbesWomen newsletter, which every Thursday morning brings news about the world’s top female entrepreneurs, leaders and investors straight to your inbox. Sign up today!

@FierceBiotech shared
On Nov 1, 2021
Zaks is treading a well-worn path between biopharma and OrbiMed, with Kevin Koch, Ph.D., Sevgi Gurkan, M.D., and Jim Sullivan, Ph.D., joining from, respectively, Biogen, Merck and AbbVie in recent years https://t.co/aoEM9v6HrU
Open
Zaks, fresh from making millions at Moderna, takes venture partner post at OrbiMed

Zaks, fresh from making millions at Moderna, takes venture partner post at OrbiMed

Tal Zaks has revealed his next job. Weeks after leaving Moderna, Zaks has taken up a venture partner post at OrbiMed—where he is joined by another storied biopharma executive.

@BentheFidler shared
On Oct 28, 2021
John Maraganore, pioneering #RNAi executive, to step down as Alnylam CEO https://t.co/kGMc4X5wY5 $ALNY
Open
John Maraganore, pioneering RNAi executive, to step down as Alnylam CEO

John Maraganore, pioneering RNAi executive, to step down as Alnylam CEO

In a move that surprised Wall Street analysts, the executive, who has overseen Alnylam's journey from startup to one of biotech's top companies, will leave by the end of the year for an ...

@FierceBiotech shared
On Nov 1, 2021
Vernalis, which China’s HitGen bought last year, has agreed to carry out all activities up to lead optimization in return for a stake in Dania https://t.co/91mOUdPIYr
Open
Gilead bought his last biotech. Now, Helin is back with another cancer startup

Gilead bought his last biotech. Now, Helin is back with another cancer startup

The founder of a biotech bought by Gilead has birthed another startup. Dania Therapeutics begins life with a discovery program based on Kristian Helin’s work and plans to advance ...

@GENbio shared
On Nov 1, 2021
Six Up-and-Coming #COVID19 Vaccines Besides Pfizer/BioNTech, Moderna, and J&J, many other biopharmas have jabs in the clinic that have shown significant protection against #SARSCoV2. Learn more: https://t.co/s0YXuqwCQV https://t.co/q6FBlnNYwf
Open
Six Up-and-Coming COVID-19 Vaccines

Six Up-and-Coming COVID-19 Vaccines

Besides Pfizer/BioNTech, Moderna, and J&J, many other biopharmas have jabs in the clinic that have shown significant protection against SARS-CoV-2.

Read more: Startups
weekly 03.11.2021
View archives
Back to home

Subscribe to Biotech Essentials - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Startups.
Privacy Policy

Sign up for the weekly Biotech Essentials - Startups newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy